Registration successful
Account activated – pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website
Zejula Resources
HCP Resources
-
Expand to See More
Zejula (niraparib) Adverse Event Management Poster
A useful guide for identifying and managing potential adverse events with Zejula.
Zejula (niraparib) Adverse Event Nurse Booklet
A booklet for nurses managing patients that have been prescribed Zejula. The booklet is available for order and/or download.
Patient Resources
-
Expand to See More
Zejula (niraparib) Patient Booklet
The patient booklet has been developed to provide information on some of the questions your patients prescribed Zejula may have and help support them on their treatment journey.
Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: www.hpra.ie . Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.
Zejula is a registered trademark of the GlaxoSmithKline group of companies.
Date of preparation: May 2023 PM-IE-NRP-WCNT-230003
